Previous 10 | Next 10 |
New data from the Phase 3 NEURO-TTRansform study evaluating WAINUA™ (eplontersen) to be presented at the 2024 International Symposium on Amyloidosis (ISA) PR Newswire – Results across NEURO-TTRansform subgroups show consistent benefit in neuropathy impairment and...
2024-05-16 13:47:53 ET More on Biogen, Ionis Pharmaceuticals Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings Biogen: Don't Overthink This One Biogen and Ionis drop ALS candidate after trial setback Eisai projects major growth for Alzheimer's therapy L...
2024-05-16 09:00:18 ET More on Biogen, Ionis, etc. Ionis Pharmaceuticals, Inc. (IONS) Q1 2024 Earnings Call Transcript Biogen: Reasons To Be Cheerful After Upbeat Q1 Earnings Biogen: Don't Overthink This One Eisai projects major growth for Alzheimer's therapy...
Development of BIIB105, an investigational antisense oligonucleotide for amyotrophic lateral sclerosis (ALS), will be discontinued based on data from the Phase 1/2 ALSpire study Biogen and Ionis continue their long-standing commitment to developing therapies for ALS given the devastating impa...
Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome PR Newswire ION582 demonstrated consistent improvements across multiple functional domains in Angelman syndrome patients ION582 was safe and well tolerated at all dose leve...
Ionis to host 2024 virtual Annual Meeting of Stockholders PR Newswire CARLSBAD, Calif. , May 15, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2024 virtual Annual Meeting of Stockholders followed ...
2024-05-15 06:47:21 ET Summary Tweedy Browne's 13F portfolio value increased to $2.13B, with 45 holdings. Berkshire Hathaway remains the largest position, followed by Alphabet, Johnson & Johnson, FMC Corporation, and Ionis Pharma. New stakes include Envista Holdings, while...
2024-05-12 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-11 06:50:00 ET Summary Tweedy, Browne Company LLC provides investment advisory services. The Company offers portfolio management, financial planning, and consulting services for individuals, institutions, partnerships, pension and profit-sharing plans, charitable foundations, ...
2024-05-09 06:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Here’s a question for you: What determines the value of a drug ? Is it the number of lives it saves or how much it costs to make? Is it the deadliness of the disease it prevents or t...
News, Short Squeeze, Breakout and More Instantly...
Ionis Pharmaceuticals Inc. Company Name:
IONS Stock Symbol:
NASDAQ Market:
Ionis Pharmaceuticals Inc. Website:
2024-06-27 11:30:07 ET Wells Fargo analyst issues BUY recommendation for IONS on June 27, 2024 09:00AM ET. The previous analyst recommendation was Buy. IONS was trading at $47.5097 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current a...
2024-06-27 11:30:06 ET Oppenheimer analyst issues UNDERPERFORM recommendation for IONS on June 27, 2024 09:00AM ET. The previous analyst recommendation was Underperform. IONS was trading at $47.5097 at issue of the analyst recommendation. The overall analyst consensus : ...
Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed PR Newswire – Olezarsen PDUFA date set for December 19, 2024 for treatment of familial chylomicronemia syndrome – – ...